相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Lori-Ann Linkins et al.
CHEST (2012)
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis
Jonathan R. Genzen et al.
TRANSFUSION (2010)
Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?
Fabrizio Follis et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)
Reduced argatroban doses after coronary artery bypass graft surgery
William D. Hoffman et al.
ANNALS OF PHARMACOTHERAPY (2008)
Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy
Alan I. Smith et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)
Argatroban Anticoagulation in Intensive Care Patients: Effects of Heart Failure and Multiple Organ System Failure
Susan M. Begelman et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2008)
Argatroban anticoagulation in critically ill patients
Martin Beiderlinden et al.
ANNALS OF PHARMACOTHERAPY (2007)
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction
Robert L. Levine et al.
CHEST (2006)
Effect of renal function on the pharmacodynamics of argatroban
PA Arpino et al.
ANNALS OF PHARMACOTHERAPY (2004)
Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
WE Dager et al.
ANNALS OF PHARMACOTHERAPY (2003)
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient
JT Edwards et al.
ANNALS OF THORACIC SURGERY (2003)
The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations
K Furukawa et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender, and hepatic or renal dysfunction
SK Swan et al.
PHARMACOTHERAPY (2000)